PROFAST Intervention in Precursor Multiple Myeloma

Clinical trial NCT05565638 · COMPLETED

Trial details

NCT number: NCT05565638
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Cancer Prevention Weight Loss Smoldering Waldenstrom Macroglobulinemia(WM)MGUS Fasting Multiple Myeloma

Start date: 2023-03-06
Primary completion: 2025-08-04
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.